WST * logo

West Pharmaceutical Services BMV:WST * Stock Report

Last Price

Mex$6.04k

Market Cap

Mex$466.7b

7D

0%

1Y

-8.6%

Updated

22 Apr, 2024

Data

Company Financials +

West Pharmaceutical Services, Inc.

BMV:WST * Stock Report

Market Cap: Mex$466.7b

WST * Stock Overview

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

WST * fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance4/6
Financial Health6/6
Dividends0/6

West Pharmaceutical Services, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for West Pharmaceutical Services
Historical stock prices
Current Share PriceUS$6,043.95
52 Week HighUS$6,682.31
52 Week LowUS$6,043.95
Beta1.02
1 Month Change0%
3 Month Changen/a
1 Year Change-8.56%
3 Year Changen/a
5 Year Changen/a
Change since IPO-26.98%

Recent News & Updates

Recent updates

Shareholder Returns

WST *MX Life SciencesMX Market
7D0%0%0%
1Y-8.6%0%0%

Return vs Industry: WST * exceeded the MX Life Sciences industry which returned -12.1% over the past year.

Return vs Market: WST * underperformed the MX Market which returned 1.4% over the past year.

Price Volatility

Is WST *'s price volatile compared to industry and market?
WST * volatility
WST * Average Weekly Movementn/a
Life Sciences Industry Average Movement0%
Market Average Movement0%
10% most volatile stocks in MX Market0%
10% least volatile stocks in MX Market0%

Stable Share Price: WST * has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine WST *'s volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
192310,600Eric Greenwww.westpharma.com

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.

West Pharmaceutical Services, Inc. Fundamentals Summary

How do West Pharmaceutical Services's earnings and revenue compare to its market cap?
WST * fundamental statistics
Market capMex$466.68b
Earnings (TTM)Mex$10.17b
Revenue (TTM)Mex$50.55b

46.3x

P/E Ratio

9.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
WST * income statement (TTM)
RevenueUS$2.95b
Cost of RevenueUS$1.82b
Gross ProfitUS$1.13b
Other ExpensesUS$536.60m
EarningsUS$593.40m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 25, 2024

Earnings per share (EPS)8.11
Gross Margin38.31%
Net Profit Margin20.12%
Debt/Equity Ratio7.2%

How did WST * perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

10%

Payout Ratio

Does WST * pay a reliable dividends?

See WST * dividend history and benchmarks
When do you need to buy WST * by to receive an upcoming dividend?
West Pharmaceutical Services dividend dates
Ex Dividend DateApr 23 2024
Dividend Pay DateMay 01 2024
Days until Ex dividend13 days
Days until Dividend pay date5 days

Does WST * pay a reliable dividends?

See WST * dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.